Chromadex Corp Company Insiders

CDXC Stock  USD 7.56  0.16  2.07%   
Chromadex Corp employs about 106 people. The company is managed by 16 executives with a total tenure of roughly 12 years, averaging almost 0.0 years of service per executive, having 6.63 employees per reported executive. Evaluation of Chromadex Corp's management performance can provide insight into the firm performance.
Frank Jaksch  CEO
Co-Founder, CEO and President and Director

Chromadex Corp's Insider Buying Vs Selling

50

 
Selling
 
Buying

Latest Trades

2024-11-22Ozan PamirAcquired 2907 @ 7.36View
2024-08-23Kristin PatrickDisposed 23000 @ 3.57View
Monitoring Chromadex Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.

Chromadex Corp's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Chromadex Corp's future performance. Based on our forecasts, it is anticipated that Chromadex will maintain a workforce of about 110 employees by January 2025.
 
Credit Downgrade
 
Yuan Drop
 
Covid

Chromadex Corp Management Team Effectiveness

As of December 2, 2024, Return On Tangible Assets is expected to decline to -0.1. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Chromadex Corp's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 28.4 M. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.
As of December 2, 2024, Common Stock Shares Outstanding is expected to decline to about 43.1 M. In addition to that, Net Loss is expected to decline to about (15.6 M)

Chromadex Corp Workforce Comparison

Chromadex Corp is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,234. Chromadex Corp holds roughly 106 in number of employees claiming about 9% of equities under Health Care industry.

Chromadex Corp Profit Margins

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.350.6076
Way Down
Slightly volatile

Chromadex Corp Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chromadex Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chromadex Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Chromadex Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.75
3
4
 11,431,715 
 11,454,715 
2024-03-01
2.0
2
1
 613,454 
 58,097 
2023-09-01
2.0
2
1
 3,490,214 
 22,436 
2023-03-01
1.0
2
2
 470,362 
 98,795 
2022-09-01
5.0
5
1
 1,236,497 
 0.00 
2022-03-01
2.0
4
2
 495,627 
 43,000 
2021-12-01
2.0
2
1
 80,000 
 250,000 
2021-03-01
0.8571
6
7
 176,954 
 345,800 
2020-12-01
1.0
2
2
 46,667 
 79,496 
2020-06-01
7.0
7
1
 121,000 
 500,000 
2020-03-01
3.5
7
2
 749,467 
 54,652 
2019-12-01
1.0
1
1
 10,000 
 30,000 
2019-03-01
3.5
14
4
 695,120 
 67,724 
2018-09-01
1.0
1
1
 5,000 
 50,000 
2018-03-01
1.0
8
8
 1,023,431 
 106,862 
2017-12-01
2.0
4
2
 2,123,440 
 116,800 
2017-09-01
3.0
6
2
 2,057,417 
 28,140 
2017-06-01
3.0
9
3
 6,446,814 
 0.00 
2016-12-01
6.0
6
1
 122,000 
 10,000 
2016-09-01
5.0
5
1
 221,500 
 8,334 
2016-06-01
2.0
2
1
 7,800 
 0.00 
2015-09-01
11.0
11
1
 1,350,000 
 0.00 
2014-03-01
10.0
10
1
 1,290,000 
 200,000 
2013-06-01
2.5
10
4
 2,343,769 
 2,203,569 
2013-03-01
0.8
4
5
 2,421,428 
 3,171,428 
2012-12-01
0.4074
11
27
 4,244,807 
 6,774,012 
2012-03-01
5.0
10
2
 5,566,664 
 0.00 
2011-12-01
1.3333
4
3
 41,000 
 5,400 
2011-09-01
1.0
2
2
 6,850,002 
 6,850,002 
2010-06-01
0.1579
3
19
 293,750 
 5,825,456 
2008-12-01
0.5
1
2
 6,225,155 
 6,225,155 

Chromadex Corp Notable Stakeholders

A Chromadex Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chromadex Corp often face trade-offs trying to please all of them. Chromadex Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chromadex Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Frank JakschCo-Founder, CEO and President and DirectorProfile
Ozan CFACFO OfficerProfile
James LeePrincipal CFOProfile
Brianna GerberSenior Director of FP&A, IR Contact OfficerProfile
Robert FriedIndependent DirectorProfile
Kendall KnyschHead PartnershipsProfile
Heather BlarcomSenior SecretaryProfile
Andrew ShaoSenior AffairsProfile
Chu YanManaging PacificProfile
David KroesSenior MattersProfile
Jason CampbellSenior DevelopmentProfile
Michiko KelleyChief OfficerProfile
Alex WorshamVice CommunicationsProfile
Tom ShumakerManaging AdvisorsProfile
Fadi KaramChief OfficerProfile
Carlos LopezSenior CounselProfile

About Chromadex Corp Management Performance

The success or failure of an entity such as Chromadex Corp often depends on how effective the management is. Chromadex Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chromadex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chromadex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.09)(0.10)
Return On Capital Employed(0.16)(0.17)
Return On Assets(0.09)(0.09)
Return On Equity(0.17)(0.18)
Please note, the presentation of Chromadex Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chromadex Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chromadex Corp's management manipulating its earnings.

Chromadex Corp Workforce Analysis

Traditionally, organizations such as Chromadex Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chromadex Corp within its industry.

Chromadex Corp Manpower Efficiency

Return on Chromadex Corp Manpower

Revenue Per Employee788.4K
Revenue Per Executive5.2M
Net Loss Per Employee46.6K
Net Loss Per Executive308.6K
Working Capital Per Employee272.8K
Working Capital Per Executive1.8M

Complementary Tools for Chromadex Stock analysis

When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets